| Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease AS Lok, LB Seeff, TR Morgan, AM Di Bisceglie, RK Sterling, TM Curto, ... Gastroenterology 136 (1), 138-148, 2009 | 798 | 2009 |
| Peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have failed prior treatment ML Shiffman, AM Di Bisceglie, KL Lindsay, C Morishima, EC Wright, ... Gastroenterology 126 (4), 1015-1023, 2004 | 650 | 2004 |
| Performance characteristics of the Abbott Architect SARS-CoV-2 IgG assay and seroprevalence in Boise, Idaho A Bryan, G Pepper, MH Wener, SL Fink, C Morishima, A Chaudhary, ... Journal of clinical microbiology 58 (8), 10.1128/jcm. 00941-20, 2020 | 625 | 2020 |
| Performance characteristics of the Abbott Architect SARS-CoV-2 IgG assay and seroprevalence in Boise, Idaho A Bryan, G Pepper, MH Wener, SL Fink, C Morishima, A Chaudhary, ... Journal of clinical microbiology 58 (8), 10.1128/jcm. 00941-20, 2020 | 625 | 2020 |
| Outcome of sustained virological responders with histologically advanced chronic hepatitis C TR Morgan, MG Ghany, HY Kim, KK Snow, ML Shiffman, JL De Santo, ... Hepatology 52 (3), 833-844, 2010 | 612 | 2010 |
| Prolonged therapy of advanced chronic hepatitis C with low-dose peginterferon AM Di Bisceglie, ML Shiffman, GT Everson, KL Lindsay, JE Everhart, ... New England Journal of Medicine 359 (23), 2429-2441, 2008 | 561 | 2008 |
| Predicting cirrhosis in patients with hepatitis C based on standard laboratory tests: results of the HALT‐C cohort ASF Lok, MG Ghany, ZD Goodman, EC Wright, GT Everson, RK Sterling, ... Hepatology 42 (2), 282-292, 2005 | 428 | 2005 |
| Identification of hepatoprotective flavonolignans from silymarin SJ Polyak, C Morishima, V Lohmann, S Pal, DYW Lee, Y Liu, TN Graf, ... Proceedings of the national academy of sciences 107 (13), 5995-5999, 2010 | 391 | 2010 |
| Sensitivity in detection of antibodies to nucleocapsid and spike proteins of severe acute respiratory syndrome coronavirus 2 in patients with coronavirus disease 2019 PD Burbelo, FX Riedo, C Morishima, S Rawlings, D Smith, S Das, ... The Journal of infectious diseases 222 (2), 206-213, 2020 | 341 | 2020 |
| Inhibition of T-cell inflammatory cytokines, hepatocyte NF-κB signaling, and HCV infection by standardized silymarin SJ Polyak, C Morishima, MC Shuhart, CC Wang, Y Liu, DYW Lee Gastroenterology 132 (5), 1925-1936, 2007 | 300 | 2007 |
| Maintenance peginterferon therapy and other factors associated with hepatocellular carcinoma in patients with advanced hepatitis C AS Lok, JE Everhart, EC Wright, AM Di Bisceglie, HY Kim, RK Sterling, ... Gastroenterology 140 (3), 840-849. e1, 2011 | 244 | 2011 |
| Coffee intake is associated with lower rates of liver disease progression in chronic hepatitis C ND Freedman, JE Everhart, KL Lindsay, MG Ghany, TM Curto, ... Hepatology 50 (5), 1360-1369, 2009 | 244 | 2009 |
| Decreased NK cell frequency in chronic hepatitis C does not affect ex vivo cytolytic killing C Morishima, DM Paschal, CC Wang, CS Yoshihara, BL Wood, AET Yeo, ... Hepatology 43 (3), 573-580, 2006 | 236 | 2006 |
| Prognostic value of Ishak fibrosis stage: findings from the hepatitis C antiviral long‐term treatment against cirrhosis trial JE Everhart, EC Wright, ZD Goodman, JL Dienstag, JC Hoefs, DE Kleiner, ... Hepatology 51 (2), 585-594, 2010 | 224 | 2010 |
| Impact of disease severity on outcome of antiviral therapy for chronic hepatitis C: lessons from the HALT‐C trial GT Everson, JC Hoefs, LB Seeff, HL Bonkovsky, D Naishadham, ... Hepatology 44 (6), 1675-1684, 2006 | 203 | 2006 |
| A prospective study of the rate of progression in compensated, histologically advanced chronic hepatitis C JL Dienstag, MG Ghany, TR Morgan, AM Di Bisceglie, HL Bonkovsky, ... Hepatology 54 (2), 396-405, 2011 | 200 | 2011 |
| Detection of nucleocapsid antibody to SARS-CoV-2 is more sensitive than antibody to spike protein in COVID-19 patients PD Burbelo, FX Riedo, C Morishima, S Rawlings, D Smith, S Das, ... MedRxiv, 2020 | 182 | 2020 |
| A first-in-human phase I study of subcutaneous outpatient recombinant human IL15 (rhIL15) in adults with advanced solid tumors JS Miller, C Morishima, DG McNeel, MR Patel, HEK Kohrt, JA Thompson, ... Clinical Cancer Research 24 (7), 1525-1535, 2018 | 180 | 2018 |
| Evolution of the HALT-C Trial: pegylated interferon as maintenance therapy for chronic hepatitis C in previous interferon nonresponders WM Lee, JL Dienstag, KL Lindsay, AS Lok, HL Bonkovsky, ML Shiffman, ... Controlled clinical trials 25 (5), 472-492, 2004 | 177 | 2004 |
| Silymarin inhibits in vitro T-cell proliferation and cytokine production in hepatitis C virus infection C Morishima, MC Shuhart, CC Wang, DM Paschal, MC Apodaca, Y Liu, ... Gastroenterology 138 (2), 671-681. e2, 2010 | 170 | 2010 |
